The Impact of Dual Antiplatelet Therapy Duration on Unruptured Aneurysm Occlusion After Flow Diversion: A Multicenter Study
Vranic J, Harker P, Stapleton C, Regenhardt R, Dmytriw A, Doron O, Alotaibi N, Leslie-Mazwi T, Gupta R, Berglar I, Tan C, Koch M, Raymond S, Mascitelli J, Patterson T, Seinfeld J, White A, Case D, Roark C, Gandhi C, Al-Mufti F, Cooper J, Matouk C, Sujijantarat N, Devia D, Ocampo-Navia M, Villamizar-Torres D, Puentes J, Patel A. The Impact of Dual Antiplatelet Therapy Duration on Unruptured Aneurysm Occlusion After Flow Diversion: A Multicenter Study. Journal Of Computer Assisted Tomography 2023, 47: 753-758. PMID: 37707405, DOI: 10.1097/rct.0000000000001457.Peer-Reviewed Original ResearchConceptsDual antiplatelet therapyAneurysm occlusion rateAneurysm occlusionDAPT durationThromboembolic complicationsOcclusion rateFlow diversionDuration of DAPTDual antiplatelet therapy durationIntracranial aneurysmsSingle Pipeline Embolization DeviceAntiplatelet therapy durationEndoluminal flow diversionRate of complicationsPrimary outcome measurePipeline Embolization DeviceSignificant differencesUnruptured intracranial aneurysmsAspirin monotherapyAntiplatelet therapyIschemic strokeTherapy durationIatrogenic complicationsRetrospective reviewMulticenter study